Tumor necrosis factor a (TNF,) stimulates granulocytemacrophage colony-stimulating factor (GM-CSF) production in human fibroblasts and other mesenchymal cells. However, relatively little is known about agents that downregulate cytokine production in these cells. In the present report we show that dexamethasone (Dexa), a synthetic glucocorticoid, markedly reduced GM-CSF production in TNF,-stimulated fibroblasts at both the protein and the RNA levels. CSF activity, GM-CSF protein, and RNA levels, determined by an in vitro colony-forming assay in normal human bone marrow cells, by an enzyme immunoassay, and by Northern blotting assay, were reduced to greater than 
noncalcitropic agent, eg, an immuno-hematopoietic horm~n e .~ Cyclosporine A (CsA), a fungal cyclic polypeptide, is another distinct immunosuppressive agent able to inhibit cytokine production in T lymphocytes. In vitro as well as in vivo studies showed that CsA downregulates IFN-y and IL-2 synthesis in murine and human T cells, but possibly not GM-CSF In contrast to T lymphocytes, less is known about the downregulation of cytokine production in mesenchymal cells. Therefore, we set out to examine whether the steroids Dexa and 1,25(OH),D,, as well as CsA, inhibit GM-CSF expression in TNF,-stimulated human fibroblasts.
MATERIALS AND METHODS

Reagents
Recombinant human TNF,, expressed in Escherichia coli, was generously provided by Dr R. Lacher (Boehringer, Ingelheim, Switzerland). The various concentrations were obtained by diluting TNF, in McCoy's medium (GIBCO, Grand Island, NY) supplemented by 10% fetal bovine serum (FBS; Nabi, Miami, FL). Dexa (Sigma Chemical Co, St Louis, MO) and 1,25(OH),D, (generously supplied by Dr A. Kaiser, Hoffmann-La Roche, Basel, Switzerland) were dissolved in 95% ethanol to a stock concentration of 1 mmolJL and stored at -20°C. CsA (a gift from Dr RyRel, Sandoz AG, Basel, Switzerland) was dissolved in ethanol, Tween-80, and McCoy's medium to a stock concentration of 1 mg/mL and stored at -20°C. The various concentrations of Dexa, 1,25(OH),D,, and CsA were obtained by diluting stock solutions in McCoy's medium. The final concentration of ethanol did not exceed 0.1%. Actinomycin D (Fluka, Buchs, Switzerland) was kept as stock solution (2 mg/mL) dissolved in dimethyl sulfoxide (DMSO). Final concentration of DMSO never exceeded 0.5% vol/vol.
Cells and Cell Culture
Normal human embryonic lung fibroblasts (WI38, purchased from the American Type Tissue Culture Collection, Rockville, MD) were cultured in McCoy's medium supplemented with 10% FBS in a humidified atmosphere containing 5% CO, at 37°C. Cells were passaged by treatment with 0.5% trypsin, 0.02% EDTA (wtkol) in Hank's solution. Subconfluent WI38 cells were cultured for variable lengths of time in the presence of TNF, (12.5 ng/mL) and various concentrations of Dexa, 1,25(OH),D,, CsA, and actinomycin D. In all experiments control samples were stimulated with TNF, alone. CSF activity of conditioned media (CM) and GM-CSF RNA levels were determined as described below. Cell viability, as determined by trypan blue exclusion, was not affected in the various experimental protocols.
Assessment of CSF Activity of CM
The biologic activity of CM was determined for its ability to stimulate normal human bone marrow myeloid colony formation (CFU-GM) in a two-layer soft agar system. Briefly, the underlayer was plated in 1-mL portions in 35-mm Petri dishes (Falcon, Becton-Dickinson, Cowley Oxford, UK) containing 0.5% agar, McCoy's medium, and 16% FBS. CM (10% [vovVol] ) from WI38 cells cultured with the various reagents were mixed into the underlayer as source of CSF. The overlayer consisted of 0.3% agar, McCoy's medium, 16% FBS, penicillin, streptomycin, and human mononuclear bone marrow cells as CSF responder cells (1 x lo5/ plate). The bone marrow cells were obtained from otherwise healthy individuals undergoing lumbar discectomy after informed consent was obtained. Mononuclear cells were isolated by FicollHypaque density gradient (1.077 g/L) (Nyegaard, Oslo, Norway). The culture dishes were incubated at 37°C in a humidified atmosphere with 5% CO,. After 10 to 13 days, the number of CFU-GM colonies defined as 2 4 0 cells were counted with an inverted microscope.
CM from fibroblasts cultured in the absence of TNF, had no CSF activity. Control dishes supplemented with CM from fibroblasts stimulated with TNF, for 48 hours displayed 58 f 22 colonies (mean f SD, n = 9). Addition of 1,25(OH),D3 (100 nmol/L), Dexa (1 pmol/L), or CsA (1.0 pg/mL) directly into CM from TNF,-stimulated W138 cells did not affect CSF activity. Finally, Dexa (1 pmol/L), 1,25(OH),D3 (100 nmoVL), and CsA (0.01 to 5 pLg/mL) did not induce CSF activity in W138 cells unstimulated with TNF,.
Assessment of GM-CSF Protein Levels
GM-CSF protein levels were measured in the supernatant by an enzyme immunoassay using a cocktail of monoclonal human GM-CSF antibodies as described." The minimal detectable amount is 0.2 ng/mL.
Assessment of GM-CSF RNA Levels
Total cellular RNA was extracted by the acid guanidinium thiocyanate phenol-chloroform method.14 RNA Samples (10 pg) were size separated by an agarose-formaldehyde gel (1%) and transferred to a nylon membrane (Hybond-N; Amersham Laboratories, Amersham, UK). Hybridization with ["PI-labeled probes (1 X lo6 cpm/mL) was for 16 to 24 hours at 42°C in 50% formamide, 2X SSC (1X SSC is 150 mmol/L NaCl, 15 mmol/L sodium citrate), 5X Denhardt's solution, 0.1% sodium dodecyl sulfate (SDS), 1 mmoVL EDTA, 10% (voVvo1) dextran sulfate (500,000 molecular weight), and 100 pg/mL salmon sperm DNA. Filters were washed to a stringency of 0.1% SSC at 6 5 T , exposed for 6 hours to 4 days at -70°C to XM-films (3M, Trimax, Ferrania, Italy). Autoradiograms were scanned by laser densitometry (LKB 2202 Ultrascan, Bromma, Sweden). No GM-CSF RNA production was detected in fibroblasts cultured in the absence of TNF,.
DNA Probes
The human GM-CSF cDNA probe (0.9 kb, EcoRI-BumHI) was derived from plasmid pCSF-1I5 and the p-actin DNA probe (0.7 kg, EcoRI-BumHI) was from plasmid pHFpA-3'~t.l~ These probes were [3ZP]-labeled by the random priming method." The GM-CSF probe detected a single 0.9-kb band consistent with GM-CSF RNA, and with the p-actin probe a single 2.1-kb band was seen in agreement with p-actin RNA.
Measurement of [3H]Thymidine Incorporation by Autoradiography
This measurement was performed as described. 18 
Parameter Estimation
Experiments measuring CSF activity were performed in triplicate and results were obtained from at least three independent experiments. All drug-induced effects were normalized with respect to control values obtained in the presence of 12.5 ng/mL TNF, only (see above) before fitting. A simple Hill-type inhibition model with a slope n = 1 was fitted by weighted nonlinear regression to the data points (Marquardt-Levenberg method, reference 19) to obtain estimates of the IC,, for the effect of Dexa (1 pmol/L) or 1,25(OH),D,. Thus: where&) is the activity expected at a concentrationx of Dexa or 1,25(OH),D3 and IC,, is the concentration required to reduce the maximal activity AM, by 50%.
RESULTS
Effect of Dexa on CSF Protein and GM-CSF RNA Levels in TNF,-Stimulated Fibroblasts
Concentration dependence. Subconfluent WI38 fibroblasts were cultured for 48 hours in the presence of TNF, (12.5 ng/mL) and Dexa (0.1 nmol/L to 1 ymol/L) (Fig IA) . Dexa reduced CSF activity in a concentration-dependent fashion with an IC,, of 0.5 ? 0.1 nmoVL (mean ? SD, n = 3). In the same fibroblasts, Dexa (1 FmoVL) reduced GM-CSF steady-state RNA levels sevenfold (data not shown). These results indicate that Dexa is a potent inhibitor of GM-CSF expression in TNF,-stimulated fibroblasts.
Specific GM-CSF protein measurement by an enzyme immunoassay yielded the following results (two independent experiments conducted in quadruplicate for each experimental point): no TNF, < 0.2 ng/mL; TNF, alone for 48 hours 1.38 ? 0.18 ng/mL (mean f SD, n = 8), TNF, and Dexa (1 ymol/L) for 48 hours < 0.2 ng/mL. These results demonstrate that Dexa is a potent inhibitor of GM-CSF expression at both the RNA and protein levels in TNF,-stimulated fibroblasts.
Time dependence. We examined whether Dexa might be able to inhibit GM-CSF production in fibroblasts prestimulated with TNF,. To study regulation of CSF protein activity, fibroblasts were stimulated for 48 hours with TNF,, Dexamethasone concentration, nM, log scale 1,25 (OH),D3 concentration, nM, log scale and Dexa (1 pmol/L) was added at various time points (Fig  2) . Dexa reduced CSF activity of CM in preactivated fibroblasts in a time-dependent manner; it was maximal when given at the same time as TNF, (t = 0) and decreased approximately linearly with time. CSF activity was reduced to 45% & 5% of its control value when Dexa was added 24 hours after the onset of TNF, stimulation.
RNA samples from fibroblasts of one representative time course experiment were analyzed by Northern blotting for GM-CSF RNA production. Here, Dexa (1 kmol/L) re-" I duced GM-CSF RNA levels approximately 10-fold in cells prestimulated for 6 and 24 hours (Fig 3A, lanes 7 and 8) . A low basal GM-CSF RNA production was seen at all time points examined. Further experiments explored in more detail the time course of GM-CSF RNA downregulation by Dexa (Fig 3B) . In these experiments TNF, was present for 6 hours, and Dexa (1 kmol/L) was added at the same time as TNF,, as well as 4, 5 , and 5.5 hours after the beginning of TNF, stimulation. Under these conditions GM-CSF RNA levels decreased 21-, 6-, 3-, and 2-fold, respectively. These results demonstrate that Dexa rapidly reduces GM-CSF RNA levels in TNF,-stimulated fibroblasts.
Experiments using actinomycin D, which blocks overall transcription, were performed to determine the t/2 of GM-CSF RNA in the presence and absence of Dexa. Fibroblasts were prestimulated for 4 hours with TNF,. Subsequently, actinomycin D alone (5 or 10 kg/mL) or actinomycin D together with Dexa (1 pmol/L,) were added for various periods of time. RNA samples were analyzed by Northern blotting for GM-CSF RNA production. Results were obtained in five independent experiments. The t/2 of GM-CSF RNA in the presence of actinomycin D alone exceeded 4 hours. A similar t/2 (> 4 hours) was observed when cells were cocultured with actinomycin D and Dexa. As demonstrated in Fig 3B, Dexa alone decreased GM-CSF RNA production by 50% within less than 1 hour. Thus, it appears that blockade of transcription by actinomycin D prevents Dexa from downregulating GM-CSF RNA production.
Determination of GM-CSF RNA half-life (t/2).
Effect of 1,25(0H)p, on CSFActivity and GM-CSF RNA Levels in TNF,-Stimulated Fibroblasts
In a similar set of experiments we applied 1,25(OH),D, in concentrations ranging from 10 pmol/L to 100 nmol/L to cultures of TNF,-
Concentration dependence.
For personal use only. on November 11, 2017. by guest www.bloodjournal.org From (Fig 1B) . In the same cells GM-CSF RNA levels were reduced fourfold at 100 nmoI/L 1,25(OH),D, (data not shown).
The effect of 1,25(OH),D3 was investigated in the same experimental settings as described above for Dexa; 1,25(OH),D3 (100 nmol/L) was added at various time points (0,3,6,12, and 24 hours) of the 48-hour TNF, stimulation (Fig 2). 1,25(OH) ,D, markedly reduced CSF activity when added up to 6 hours after onset of TNF, stimulation, but it had no effect when added after 12 and 24 hours of stimulation.
Virtually no inhibition of GM-CSF RNA production was seen in cells exposed concurrently to TNF, and 100 nmoln 1,25(OH),D3 for the first 6 hours (Fig 3C, lane 5) . However, 1,25(OH),D, was capable of reducing GM-CSF RNA production about fivefold when added simultaneously with TNF, for 24 and 48 hours (lanes 6 and 7). 1,25(OH),D3 caused a 1.7-fold reduction of GM-CSF RNA levels when added 6 hours after onset of a 48-hour stimulation (lane 8).
In contrast, GM-CSF RNA levels were not affected by the 1,25(OH),D, when added 24 hours after onset of stimulation (lane 9). Both IC,, and time course suggest that 1,25(OH),D, reduces GM-CSF production at both the protein and RNA level, but that the repression is less pronounced than with Dexa.
Time dependence.
Effect of CsA on CSF-Protein Activity and GM-CSF RNA Levels in TNF,-Stimulated Fibroblasts Concentration dependence. Subconfluent fibroblasts were cultured for 48 hours in the presence of TNF, alone or TNF, and CsA (0.01 to 5 p,g/mL) (Fig 4) . Concentrations of CsA up to 1 pg/mL had no effect on either CSF activity or GM-CSF RNA levels. With 5 &mL CsA, CSF activity and GM-CSF RNA levels were reduced to 47% f 6% and 50%, respectively. This suggests that CsA has no major impact on GM-CSF production in TNF,-stimulated fibroblasts.
Effect of Dexa and 1 , 2 5 ( 0 H ) p , on Proliferation of
TNF,-Stimulated Fibroblasts as Determined by ['HI Thymidine Incorporation
Subconfluent fibroblasts were cultured in the presence of TNF, and Dexa (1 kmol/L) or 1,25(OH),D, (100 nmol/L) for 48 hours. The fraction of labeled cells (FLC) was determined as described in the Materials and Methods section. The true FCL values for the controls (48 hours exposure to TNF, only) were 32% f 9.5% (mean f SD, n = 28). FLC values were normalized with respect to these controls (48 hours TNF, exposure = 100%). The data of four independent experiments (each one with n 2 4) were the following: no additives, 66% f 7%; Dexa (1 kmol/L), 104% +-10%; and 1,25(OH),D3 (100 nmol/L), 55% f 6%.
These results demonstrate that 1,25(OH),D3, but not Dexa, inhibits the proliferation of TNF,-stimulated fibroblasts. The data further suggest that the inhibitory effect of 1,25(OH),D3 on GM-CSF expression may be due, at least in part, to repression of cell proliferation.
DISCUSSION
Previous studies have shown that glucocorticoids modulate the expression of certain genes. For example, Dexa induces expression of the genes for the acute-phase reactant a-1 glycoprotein, growth hormone, metallothionein, and alcoholdehydr~genase?~~~~ In contrast, Dexa decreases production of IL-2 and IFN-y in activated T lymphocytes and type I procollagen in fibr~blasts.~,~~ We now demonstrate that Dexa markedly reduced GM-CSF gene expression in TNF*-stimulated human fibroblasts at both the RNA and protein levels. CSF activity was reduced by 50% at approximately 0.5 nmoln Dexa, a level that is readily achieved during glucocorticoid therapy in clinical practice; eg, at doses of 25 to 50 mg of prednisone daily?5 At the RNA level, GM-CSF production was reduced to approximately 50% of its control value within less than 1 hour after exposure to Dexa. This indicates that the inhibitory effect of Dexa cannot be attributed to inhibition of cell proliferation, as further supported by our finding that Dexa did not cause a decrease of DNA synthesis.
1,25(OH),D,, the most active metabolite of vitamin D,, is another steroid hormone that regulates expression of a number of genes in various tissues? For instance, we as well as others have demonstrated that 1,25(OH),D3 downregulates gene expression of lymphokines, such as GM-CSF, IFN-y, and IL-2 in activated T Our present study shows that 1,25(OH),D3 inhibited GM-CSF gene expression in TNF,-stimulated fibroblasts in a concentration-and time-dependent manner. A 50% reduction of CSF activity was obtained at approximately 1.5 nmol/L 1,25(OH),D,. The potency of 1,25(OH),D, to reduce GM-CSF production is consistent with a receptor-mediated effect, although our data only provide circumstantial evidence for such a mechanism. Our IC,, for 1,25(OH),D3 is, nonetheless, consistent with the reported equilibrium dissociation constant of 0.4 nmol/L.= 1,25(OH),D3 must be added simultaneously with TNF, to the fibroblasts to achieve a marked reduction of both CSF activity and GM-CSF RNA production; no reduction was observed when the hormone was added to fibroblasts preactivated for more than 6 hours. Taken together, our data suggest that 1,25(OH),D, regulates GM-CSF gene expression in human fibroblasts, but less effectively than Dexa. Nevertheless, our findings yield further evidence for a possible role of 1,25(OH),D3 in noncalcitropic tissues such as the immunohematopoietic system. Possible mechanisms of gene downregulation by steroid hormones include repression of transcriptional activityz7 and alteration of RNA stability. For instance, glucocorticoids inhibit transcriptional activity of the pro-opiomelanocortin gene,% reduce both transcription and stability of IL-1 RNA in the monocytic U937 cells? and 1,25(OH),D3 decreases stability of GM-CSF RNA in T lymphocyte^.^"
Our measurements of GM-CSF RNA half-life in experiments using actinomycin D indicate that Dexa alters GM-CSF RNA stability. Dexa may possibly affect GM-CSF RNA stability via the recognition of RNA degradation sites by RNAses. These enzymes might interfere with the AUrich sequences from the 3' untranslated region present in Several studies have demonstrated that CsA inhibits expression of certain lymphokines in activated human and murine T lymphocytes, such as IL-2, IL-3, and IFN-y.''-'2 In contrast, GM-CSF production was not repressed in activated murine T lymphocytes, suggesting a differential control mechanism for lymphokine expression in T cells." We found that CsA did not change GM-CSF expression in TNF,-stimulated fibroblasts at moderate to rather high concentrations exceeding those usually achieved during CsA therapy. A 50% reduction was merely seen at an excessively high concentration (5 pglmL). As suggested in a previous report, this reduction might be due to a nonspecific inhibition of RNA polymerase I1 by CsA?' Taken together our in vitro results show that Dexa, and to a lesser extent 1,25(OH),D,, repress GM-CSF gene expression in TNF,-stimulated fibroblasts. These results might point to a mechanism of how these agents may impair host defense, attenuate neutrophil-mediated tissue damage, and influence inflammatory processes.
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